April 17, 2008
HEMOBIOTECH TO PRESENT AT THE EQUITIES 57TH ANNIVERSARY SPRING CONFERENCE
Full Release >>
March 26, 2008
HemoBioTech Featured on Fox News
Full Release >>
February 28, 2008
HemoBioTech’s CEO, Arthur Bollon, PhD, To Present At MedTech Insight In3 Conference
Full Release >>
January 29, 2008
HemoBioTech, Inc. Updates Financial and Media News
Full Release >>
January 16, 2008
HemoBioTech, Inc. Featured in New Scientist Magazine
Full Release >>
December 7, 2007
HemoBioTech Featured In Flaherty Financial News, Inc.
Full Release >>
November 20, 2007
HemoBioTech's Human Blood Substitute, HemoTech, Highlighted in Scientific American Online
Full Release >>
November 2, 2007
HemoBioTech's CEO to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007 in New York City
Full Release >>
October 4, 2007
HemoTech Findings Show Significant Promise For Combating Two Major Complications Involved In Treating Patients With Coronary Artery Disease
Full Release >>
October 1, 2007
HemoBioTech, Inc. Retains the Investor Relations Group, Inc.
Full Release >>
August 13, 2007
Blood substitute update: HemoBioTech Chairman and CEO Dr. Arthur Bollon to give presentation tomorrow, August 14th, about the development of HemoTech, at the ''FFN & WSR Small Cap Conference'' in New York City
Full Release >>
July 31, 2007
HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give Update Tomorrow in Dallas on the Company and Development of Its Artificial Blood Product, HemoTech
Full Release >>
July 19, 2007
HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give Update Today on the Company and Development of Its Artificial Blood Product, HemoTech
Full Release >>
July 17, 2007
HemoBioTech Takes the Next Step to Facilitate Clinical Study in India of its Human Blood Substitute, HemoTech Promoting Saraswathy Swaminathan to Manager of Foreign Clinical Affairs
Full Release >>
June 21, 2007
HemoBioTech Engages CRO to Facilitate Clinical Study in India of Its Human Blood Substitute, HemoTech
Full Release >>
May 15, 2007
HemoBioTech CEO Dr. Arthur Bollon to Present at the RENN Investor Conference in Dallas on May 18, 2007
Full Release >>
May 9, 2007
HemoBioTech, Inc. Retains Ronald Trahan Associates, Inc.:
Full Release >>
March 20, 2007
HEMOBIOTECH CEO TO PRESENT 16th ANNUAL ROYSTON C. CLOWES MEMORIAL LECTURE SERIES
Full Release >>
Feburary 26, 2007
HEMOBIOTECH TO PRESENT AT 2007 MEDTECH CONFERENCE
Full Release >>
February 1, 2007
HEMOBIOTECH ANNOUNCES EXPANSION OF FACILITIES
Full Release >>
January 31, 2007
HEMOBIOTECH EXPANDS SPONSORED RESEARCH AGREEMENT WITH TEXAS TECH UNIVERSITY
Full Release >>
December 28, 2006
HEMOBIOTECH CHIEF EXECUTIVE OFFICER PROVIDES YEAR END REVIEW AND ADDRESSES GLOBAL STRATEGY
Full Release >>
September 27, 2006
HEMOBIOTECH TO PRESENT AT NanoTX ‘06
Full Release >>
July 17, 2006
HEMOBIOTECH ANNOUNCES CONVERSION OF CLASS A WARRANTS
Full Release >>
June 22, 2006
HEMOBIOTECH INTRODUCES NEW WEBSITE
Full Release >>
June 12, 2006
HEMOBIOTECH ANNOUNCES REDEMPTION OF WARRANTS
Full Release >>
May 18, 2006
HEMOBIOTECH ANNOUNCES FILING OF PATENT APPLICATION FOR BLOOD LOSS TREATMENT
Full Release >>
May 4, 2006
HEMOBIOTECH WILL PRESENT AT RENN INVESTOR CONFERENCE
Full Release >>
February 22, 2006
HEMOBIOTECH TO MAKE PRESENTATION AT MEDTECH CONFERENCE
Full Release >>
February 6, 2006
HEMOBIOTECH ANNOUNCES EXERCISE OF WARRANTS BY RENN CAPITAL
Full Release >>
January 18, 2006
HemoBioTech Signs Third Stage Sponsored Research Agreement with Texas Tech University Health Sciences Center
Full Release >>
December 22, 2005
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on HemoBioTech, Inc.
Full Release >>
December 21, 2005
HEMOBIOTECH, INC. ENGAGES REGULUS FOR FDA SERVICES
Full Release >>
November 11, 2005
HEMOBIOTECH, INC. COMMON STOCK QUOTED on OTCBB
Full Release >>
August 17, 2005
HEMOBIOTECH ANNOUNCES CONVERSION OF $750,000 AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE PROMISSORY NOTES
Full Release >>
01/13/2008
Dallas Morning News
Research Field Going Strong
Full Coverage >>
01/05/2008
New Scientist Magazine
Fresh Hope for Emergency Blood Substitutes
Full Coverage >>
December 16, 2006
DallasCEO
Finding a Red Blood Cell Substitute
Full Coverage >>
July 17, 2006
Dallas Morning News
HemoBioTech gains proceeds of $5.5 million
Full Coverage >>
January 14, 2006
Dallas Morning News
Blood substitute may boost biotech; If Dallas firm's product proves viable, it could make billions.
Full Coverage >>
November 08, 2004
Dallas Business Journal
On November 08, 2004, HemoBioTech, Inc. made headlines in Dallas Business Journal on its successful completion of private placement securing $4.5 million in venture capital.
Full Coverage >>
October 16, 2003
Nature Publishing Group
On October 16, 2003, the Nature Publishing Group covered a story on Texas Tech University blood substitute production facility that HemoBioTech Inc. uses for production of HemoTech™.
Full Coverage >>
Simoni, J. (2005). Endothelial Cell Response to Hemoglobin Based Oxygen Carriers. Is the Attenuation of Pathological Reactions Possible? In K. Kobayashi; E. Tsuchida ; Horinouchi & Hirohisha,(Eds),Artificial Oxygen Carrier - Its Frontline. (pp . 75-126). Tokyo, Japan : Springer - Verlog
Simoni J, Simon G, Martinez - Zaguilan R, Wesson D, Lox C, Prien S, Vijay Kumar R,: Improved Blood Substitute: Evaluation of Its Effects on Human Endothelial Cells. American Society for Artificial Internal Organs – 44: M356-M367,1998
Simoni J, Feola M, Simoni G, Hartsell A, : An Improved blood Substitute : In Vivo Evaluation of Its Renal Effects. American Society for Artificial Internal Organs – 43: M714-M725,1997
Simoni J, Simoni G, Feola M ,Newman G, : An Improved blood Substitute: In Vivo Evaluation of Its Hemodynamic Effects. American Society for Artificial Internal Organs – 42: M773-M782,1996
Simoni J, Feola M, Angelillo R, Luhruma Z, Kabakele M, Manzombi M, Kaluila M : Clinical Trial of a Hemoglobin based blood substitute in patients with Sickle Cell Anemia. Surgical Gynecology & Obstetrics,Surgery, Gynecology & Obstetrics – 174 : 379-386, 1992